Differences in functional outcome of COVID-19 and non-COVID-19 patients with critical illness polyneuropathy/ myopathy: a multicenter cohort study.

IF 4.6 2区 医学 Q1 CLINICAL NEUROLOGY Journal of Neurology Pub Date : 2025-02-11 DOI:10.1007/s00415-024-12873-5
Michael Klein, Bernadette Einhäupl, Eva Grill, Gergana Drunin, Simone Schmidt, Cay Cordes, Marion Egger, Hans-Jürgen Gdynia, Anna Gorsler, Danae Götze, Jens Dieter Rollnik, Martin Justinus Rosenfelder, Ernst Walther, Daniel Wertheimer, Corinna Wimmer, Peter Young, Klaus Jahn, Andreas Bender
{"title":"Differences in functional outcome of COVID-19 and non-COVID-19 patients with critical illness polyneuropathy/ myopathy: a multicenter cohort study.","authors":"Michael Klein, Bernadette Einhäupl, Eva Grill, Gergana Drunin, Simone Schmidt, Cay Cordes, Marion Egger, Hans-Jürgen Gdynia, Anna Gorsler, Danae Götze, Jens Dieter Rollnik, Martin Justinus Rosenfelder, Ernst Walther, Daniel Wertheimer, Corinna Wimmer, Peter Young, Klaus Jahn, Andreas Bender","doi":"10.1007/s00415-024-12873-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Up to 80% of intensive care unit (ICU) patients suffer from neuromuscular disorders like critical illness polyneuropathy/myopathy (CIP/CIM), requiring further rehabilitation.</p><p><strong>Objective: </strong>This study investigates differences in the clinical course between Coronavirus Disease 2019 (COVID-19) and non-COVID-19 patients with CIP/CIM undergoing post-acute neurological rehabilitation (PANR) and the impact of COVID-19 on rehabilitation outcomes.</p><p><strong>Methods: </strong>A multicenter observational study was conducted in nine German PANR facilities. The clinical course and outcome were compared between COVID-19 and non-COVID-19 patients at rehabilitation admission and discharge. Functional outcomes were measured with the modified Ranking Scale (mRS) and the Barthel Index (BI). Functional independence was defined as either mRS Score < 3 or BI > 75 at discharge, discharged home without nursing support with a BI > 65, or discharged to further rehabilitation (phase D). To analyze outcome predictors, Cox regression was used.</p><p><strong>Results: </strong>A total of 323 patients (COVID-19 n = 166) after an ICU stay were enrolled, and outcome measures were available for 298. 56 of them achieved functional independence at discharge. COVID-19 patients had better functional scores at admission and discharge and a shorter length of stay as the non-COVID group. Pre-existing diabetes was significantly negatively associated with functioning at discharge.</p><p><strong>Conclusions: </strong>This analysis provides the first evidence for differences and predictors of the clinical course and outcome for COVID-19 and non-COVID-19 patients with CIP/CIM in the phase of post-acute rehabilitation. Our results offer valuable impulses for rehabilitation strategies for these patients. https://drks.de/search/de , German Clinical Trials Register, ID DRKS00022845, registered on September 1, 2020.</p>","PeriodicalId":16558,"journal":{"name":"Journal of Neurology","volume":"272 3","pages":"197"},"PeriodicalIF":4.6000,"publicationDate":"2025-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Neurology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00415-024-12873-5","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Up to 80% of intensive care unit (ICU) patients suffer from neuromuscular disorders like critical illness polyneuropathy/myopathy (CIP/CIM), requiring further rehabilitation.

Objective: This study investigates differences in the clinical course between Coronavirus Disease 2019 (COVID-19) and non-COVID-19 patients with CIP/CIM undergoing post-acute neurological rehabilitation (PANR) and the impact of COVID-19 on rehabilitation outcomes.

Methods: A multicenter observational study was conducted in nine German PANR facilities. The clinical course and outcome were compared between COVID-19 and non-COVID-19 patients at rehabilitation admission and discharge. Functional outcomes were measured with the modified Ranking Scale (mRS) and the Barthel Index (BI). Functional independence was defined as either mRS Score < 3 or BI > 75 at discharge, discharged home without nursing support with a BI > 65, or discharged to further rehabilitation (phase D). To analyze outcome predictors, Cox regression was used.

Results: A total of 323 patients (COVID-19 n = 166) after an ICU stay were enrolled, and outcome measures were available for 298. 56 of them achieved functional independence at discharge. COVID-19 patients had better functional scores at admission and discharge and a shorter length of stay as the non-COVID group. Pre-existing diabetes was significantly negatively associated with functioning at discharge.

Conclusions: This analysis provides the first evidence for differences and predictors of the clinical course and outcome for COVID-19 and non-COVID-19 patients with CIP/CIM in the phase of post-acute rehabilitation. Our results offer valuable impulses for rehabilitation strategies for these patients. https://drks.de/search/de , German Clinical Trials Register, ID DRKS00022845, registered on September 1, 2020.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
COVID-19与非COVID-19重症多发性神经病变/肌病患者功能结局的差异:一项多中心队列研究
背景:高达80%的重症监护病房(ICU)患者患有神经肌肉疾病,如重症多发性神经病变/肌病(CIP/CIM),需要进一步康复。目的:探讨2019冠状病毒病(COVID-19)与非COVID-19 CIP/CIM患者急性后神经康复(PANR)的临床病程差异及COVID-19对康复结果的影响。方法:在德国9家PANR机构进行多中心观察研究。比较新冠肺炎患者和非新冠肺炎患者在康复入院和出院时的临床病程和转归。功能结果采用改良排名量表(mRS)和Barthel指数(BI)进行测量。功能独立性定义为出院时mRS评分75,出院时无护理支持,BI评分为bbb65,或出院后进一步康复(D期)。为了分析结果预测因素,使用Cox回归。结果:共纳入323例ICU住院患者(COVID-19 n = 166),其中298例可获得结局测量值。其中56例出院时功能独立。新冠肺炎患者入院和出院时功能评分高于非新冠肺炎患者,住院时间短于非新冠肺炎患者。先前存在的糖尿病与出院时的功能显著负相关。结论:本分析首次提供了COVID-19和非COVID-19 CIP/CIM患者急性后康复期临床病程和预后差异的证据和预测因素。我们的结果为这些患者的康复策略提供了有价值的推动力。https://drks.de/search/de,德国临床试验注册,编号DRKS00022845,于2020年9月1日注册。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Neurology
Journal of Neurology 医学-临床神经学
CiteScore
10.00
自引率
5.00%
发文量
558
审稿时长
1 months
期刊介绍: The Journal of Neurology is an international peer-reviewed journal which provides a source for publishing original communications and reviews on clinical neurology covering the whole field. In addition, Letters to the Editors serve as a forum for clinical cases and the exchange of ideas which highlight important new findings. A section on Neurological progress serves to summarise the major findings in certain fields of neurology. Commentaries on new developments in clinical neuroscience, which may be commissioned or submitted, are published as editorials. Every neurologist interested in the current diagnosis and treatment of neurological disorders needs access to the information contained in this valuable journal.
期刊最新文献
Treatment-free remission in MS: long-term disease control with cladribine tablets. Real-world safety of satralizumab in neuromyelitis optica spectrum disorder: a FAERS-based risk stratification study. Quantitative susceptibility mapping of dentate nucleus iron in SCA6 and SCA31: comparison with pathological findings. Prevalence and profiles of clinically diagnosed autoimmune cerebellar ataxia in a Japanese nationwide survey. Correction: Giovanni Algeri (1857-1927).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1